STOCK TITAN

ALLIENT INC (ALNT) SEC Filings, Mar 10-26, 2026

ALNT NASDAQ

Welcome to our dedicated page for ALLIENT SEC filings (Ticker: ALNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Allient Inc. SEC filings document proxy governance for a Nasdaq-listed operating company that designs and manufactures Motion, Controls and Power products. The company’s definitive proxy materials cover annual meeting matters, director elections, advisory approval of named executive officer compensation, independent auditor ratification and shareholder voting procedures. These filings provide formal records of board oversight, executive-compensation governance and shareholder actions associated with Allient’s public-company structure.

Rhea-AI Summary

Allient Inc Schedule 13G/A amendment: The Vanguard Group reports it beneficially owns 0 shares of Allient Inc common stock, representing 0% of the class. The filing notes an internal realignment effective January 12, 2026 leading certain Vanguard subsidiaries to report separately. The amendment is signed on 03/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Winter Michael R reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC director Michael R. Winter received a grant of 374 shares of Common Stock as part of his quarterly retainer. The award was made on March 5, 2026 under the company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan at a price of $62.07 per share.

After this equity grant, he directly holds 39,341 shares of Allient common stock. In addition, he has an indirect holding of 847 shares through an individual 401(k) plan, reflecting retirement-related ownership separate from his direct stake.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tzetzo Nicole R reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC director Nicole R. Tzetzo received a grant of 374 shares of common stock as part of her quarterly retainer on the company’s 2017 Omnibus Incentive Plan. The award on March 5, 2026 was recorded at $62.07 per share and increased her directly held shares to 14,232.

The filing also reports 600 shares held indirectly through a general partnership associated with her spouse. She disclaims beneficial ownership of those indirectly held shares except to the extent of her spouse’s pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Finch Steven C. reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC director Steven C. Finch received an award of 374 shares of common stock on March 5, 2026. The shares were granted as part of his quarterly retainer under the company’s Non-Employee Director Compensation Policy within the 2017 Omnibus Incentive Plan at a price reference of $62.07 per share.

After this grant, Finch directly holds a total of 13,005 shares of Allient common stock. This reflects equity-based compensation rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Federico Richard D reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC director Richard D. Federico received an equity grant of 433 shares of Common Stock as part of his quarterly retainer. The award was made on March 5, 2026 under the company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan. After this grant, he directly owns 76,563 shares of Allient common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Engel Robert B reported acquisition or exercise transactions in this Form 4 filing.

Allient Inc. director Robert B. Engel received a grant of 374 shares of common stock as part of his quarterly retainer. The shares were valued at $62.07 per share and were awarded under the Company’s Non-Employee Director Compensation Policy and 2017 Omnibus Incentive Plan. After this grant, Engel directly owns 32,237 Allient common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Warzala Stephen reported acquisition or exercise transactions in this Form 4 filing.

ALLIENT INC executive Stephen Warzala, VP and Group President, reported equity awards of common stock as part of his compensation. He received 1,664 time-based restricted shares that vest one-third each on April 1, 2027, 2028 and 2029. He was also granted 1,189 performance-based restricted shares that may vest over three years if performance goals for the year ending December 31, 2026 are met, and 345 performance-based restricted shares that were earned based on 2025 goals and vest one-third each on April 1, 2026, 2027 and 2028. Following these awards, his directly held common stock increased in stages to 36,028 shares, with additional indirect holdings reported through various trusts and an ESOP trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

May Kenneth Arthur reported acquisition or exercise transactions in this Form 4 filing.

Allient Inc. Chief Technology Officer Kenneth Arthur May reported equity awards of common stock on March 5, 2026. He received 1,048 time-based restricted shares at $62.07 per share that vest in three equal parts on April 1 of 2027, 2028 and 2029.

He was also granted 838 performance-based restricted shares that may vest over a three-year period based on goals set for the year ending December 31, 2026, and 285 performance-based restricted shares that were earned on goals for 2025 and vest one-third each on April 1 of 2026, 2027 and 2028. The filing also shows 1,228 shares held indirectly through an ESOP trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ALLIENT INC reported that VP and Group President Helmut Pirthauer acquired 1,552 shares of common stock through a grant of time-based restricted shares under the company’s 2017 Omnibus Incentive Plan at $62.07 per share. Total direct holdings increased to 46,053 shares after this award.

The restricted shares vest in three equal installments, with one-third scheduled to vest on April 1, 2027, one-third on April 1, 2028, and the final third on April 1, 2029, aligning the executive’s compensation with longer-term company performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ALLIENT INC VP and Group President Ashish Bendre reported equity awards of company stock. On March 5, 2026, he acquired a total of 3,032 shares of common stock as stock grants valued at $62.07 per share under the 2017 Omnibus Incentive Plan.

The awards include time-based restricted shares that vest in three equal parts on April 1, 2027, 2028, and 2029, and performance-based restricted shares tied to goals for the years ending December 31, 2025 and December 31, 2026. He also reports 1,155 indirectly held shares through an ESOP Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many ALLIENT (ALNT) SEC filings are available on StockTitan?

StockTitan tracks 60 SEC filings for ALLIENT (ALNT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ALLIENT (ALNT)?

The most recent SEC filing for ALLIENT (ALNT) was filed on March 26, 2026.